Abstract
Cardiac amyloidosis is a rare cause of cardiomyopathy, reported exclusively in adults. We report the first known case presenting in childhood. A 12-year-old boy presented with syncope and diagnosed with ventricular non-compaction by echocardiography. Eventual genetic testing confirmed a TTR gene mutation associated with hereditary transthyretin amyloidosis.
Similar content being viewed by others
References
Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS (2019) Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol 73(22):2872–2891. https://doi.org/10.1016/j.jacc.2019.04.003
Rapezzi C, Merlini G, Quarta CC et al (2009) Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation 120(13):1203–1212. https://doi.org/10.1161/CIRCULATIONAHA.108.843334
Maurer MS, Bokhari S, Damy T et al (2019) Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis. Circ Heart Fail 12(9):e006075. https://doi.org/10.1161/CIRCHEARTFAILURE.119.006075
Gillmore JD, Damy T, Fontana M et al (2018) A new staging system for cardiac transthyretin amyloidosis. Eur Heart J 39(30):2799–2806. https://doi.org/10.1093/eurheartj/ehx589
Damy T, Costes B, Hagège AA et al (2016) Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness. Eur Heart J 37(23):1826–1834. https://doi.org/10.1093/eurheartj/ehv583
Yuan L, Xie M, Cheng TO et al (2014) Left ventricular noncompaction associated with hypertrophic cardiomyopathy: echocardiographic diagnosis and genetic analysis of a new pedigree in China. Int J Cardiol 174(2):249–259. https://doi.org/10.1016/j.ijcard.2014.03.006
Rapezzi C, Quarta CC, Obici L et al (2013) Disease profile and differential diagnosis of hereditary transthyretin-related amyloidosis with exclusively cardiac phenotype: an Italian perspective. Eur Heart J 34(7):520–528. https://doi.org/10.1093/eurheartj/ehs123
Emdin M, Aimo A, Rapezzi C et al (2019) Treatment of cardiac transthyretin amyloidosis: an update. Eur Heart J 40(45):3699–3706. https://doi.org/10.1093/eurheartj/ehz298
Funding
The author(s) received no financial support for the research, authorship, and/or publication of this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest relevant to this article to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Torpoco Rivera, D.M., Williams, C.T. & Karpawich, P.P. Cardiac Amyloidosis in a Child Presenting with Syncope: The First Reported Case and a Diagnostic Dilemma. Pediatr Cardiol 43, 700–703 (2022). https://doi.org/10.1007/s00246-021-02778-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-021-02778-9